Read + Share
Amedeo Smart
Independent Medical Education
Takahashi R, Yamamoto K, Toya H, Shoji H, et al. A selective RPL15 PROTAC degrader enhances anti-PD-1 immunotherapy in a murine melanoma tumor model. Oncogene 2025 Nov 23. doi: 10.1038/s41388-025-03641.PMID: 41276688
Email
LinkedIn
Privacy Policy